Skip to main content

Advertisement

Log in

Inborn errors of metabolism for the diagnostic radiologist

  • Review
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Inherited metabolic disorders are becoming more important with the increasing availability of diagnostic methods and therapies for these conditions. The radiologist has become an important link in making the diagnosis or collaborating with the specialist centre to diagnose these disorders and monitor effects of therapy. The modes of presentation, disease-specific groups, classic radiological features and investigations are explored in this article to try and give the general radiologist some crucial background knowledge. The following presentations are covered: acute intoxication, hypoglycaemia, developmental delay and storage features. Specific groups of disorders covered are the abnormalities of intermediary metabolism, disorders of fatty acid oxidation and ketogenesis, mitochondrial disorders, lysosomal storage disorders, and, briefly, other groups such as peroxisomal disorders, disorders of glycosylation, and creatine synthesis disorders. New advances and the demands for monitoring are also briefly explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Garrod A (1902) The incidence of alkaptonuria: a study in chemical individuality. Lancet 2:1616–1620

    Article  CAS  Google Scholar 

  2. Cleary MA, Walter JH, Wraith JE et al (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255

    Article  PubMed  CAS  Google Scholar 

  3. Santra S, Baumann U (2008) Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother 9:1229–1236

    Article  PubMed  CAS  Google Scholar 

  4. Sener RN (2005) Tyrosinemia: computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain. J Comput Assist Tomogr 29:323–325

    Article  PubMed  Google Scholar 

  5. Perrone A, Impara L, Bruni A et al (2005) Radiographic and MRI findings in ochronosis. Radiol Med (Torino) 110:349–358

    Google Scholar 

  6. Gaines JJ Jr, Pai GM (1987) Cardiovascular ochronosis. Arch Pathol Lab Med 111:991–994

    PubMed  Google Scholar 

  7. Lu CY, Hou JW, Wang PJ et al (1996) Homocystinuria presenting as fatal common carotid artery occlusion. Pediatr Neurol 15:159–162

    Article  PubMed  CAS  Google Scholar 

  8. Herrmann M, Widmann T, Herrmann W (2005) Homocysteine – a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 43:1111–1117

    Article  PubMed  CAS  Google Scholar 

  9. Dublin AB, Hald JK, Wootton-Gorges SL (2002) Isolated sulfite oxidase deficiency: MR imaging features. AJNR 23:484–485

    PubMed  Google Scholar 

  10. Hoffmann C, Ben Zeev B, Anikster Y et al (2007) Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency. J Child Neurol 22:1214–1221

    Article  PubMed  Google Scholar 

  11. Schonberger S, Schweiger B, Schwahn B et al (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75

    Article  PubMed  CAS  Google Scholar 

  12. Parmar H, Sitoh YY, Ho L (2004) Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr 28:93–97

    Article  PubMed  Google Scholar 

  13. Jan W, Zimmerman RA, Wang ZJ et al (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393–399

    Article  PubMed  Google Scholar 

  14. Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270

    Article  PubMed  CAS  Google Scholar 

  15. Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR 16:675–683

    PubMed  CAS  Google Scholar 

  16. Whelan DT, Hill R, Ryan ED et al (1979) L-Glutaric acidemia: investigation of a patient and his family. Pediatrics 63:88–93

    PubMed  CAS  Google Scholar 

  17. Barbot C, Fineza I, Diogo L et al (1997) L-2-Hydroxyglutaric aciduria: clinical, biochemical and magnetic resonance imaging in six Portuguese pediatric patients. Brain Dev 19:268–273

    Article  PubMed  CAS  Google Scholar 

  18. Clarke NF, Andrews I, Carpenter K et al (2003) D-2-hydroxyglutaric aciduria: a case with an intermediate phenotype and prenatal diagnosis of two affected fetuses. Am J Med Genet 120A:523–527

    Article  PubMed  Google Scholar 

  19. van der Knaap MS, Jakobs C, Hoffmann GF et al (1999) D-2-hydroxyglutaric aciduria: further clinical delineation. J Inherit Metab Dis 22:404–413

    Article  PubMed  Google Scholar 

  20. Kwong KL, Mak T, Fong CM et al (2002) D-2-Hydroxyglutaric aciduria and subdural haemorrhage. Acta Paediatr 91:716–718

    Article  PubMed  CAS  Google Scholar 

  21. Sugita K, Kakinuma H, Okajima Y et al (1995) Clinical and MRI findings in a case of D-2-hydroxyglutaric aciduria. Brain Dev 17:139–141

    Article  PubMed  CAS  Google Scholar 

  22. Talkhani IS, Saklatvala J, Dwyer J (2000) D-2-hydroxyglutaric aciduria in association with spondyloenchondromatosis. Skeletal Radiol 29:289–292

    Article  PubMed  CAS  Google Scholar 

  23. Honey EM, van Rensburg M, Knoll DP et al (2003) Spondyloenchondromatosis with D-2-hydroxyglutaric aciduria: a report of a second patient with this unusual combination. Clin Dysmorphol 12:95–99

    Article  PubMed  CAS  Google Scholar 

  24. Kjaergaard S, Graem N, Larsen T et al (1998) Recurrent fetal polycystic kidneys associated with glutaric aciduria type II. APMIS 106:1188–1193

    PubMed  CAS  Google Scholar 

  25. Takanashi J, Fujii K, Sugita K et al (1999) Neuroradiologic findings in glutaric aciduria type II. Pediatr Neurol 20:142–145

    Article  PubMed  CAS  Google Scholar 

  26. Firat AK, Karakas HM, Yakinci C (2006) Magnetic resonance spectroscopic characteristics of glutaric aciduria type II. Dev Med Child Neurol 48:847–850

    Article  PubMed  Google Scholar 

  27. Brismar J, Ozand PT (1994) CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR 15:1459–1473

    PubMed  CAS  Google Scholar 

  28. Yalcinkaya C, Dincer A, Gunduz E et al (1999) MRI and MRS in HMG-CoA lyase deficiency. Pediatr Neurol 20:375–380

    Article  PubMed  CAS  Google Scholar 

  29. Ozand PT, Rashed M, Gascon GG et al (1994) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16 [Suppl]:38–45

    Article  PubMed  Google Scholar 

  30. Leijser LM, de Vries LS, Rutherford MA et al (2007) Cranial ultrasound in metabolic disorders presenting in the neonatal period: characteristic features and comparison with MR imaging. AJNR 28:1223–1231

    PubMed  CAS  Google Scholar 

  31. Takeoka M, Soman TB, Shih VE et al (2001) Carbamyl phosphate synthetase 1 deficiency: a destructive encephalopathy. Pediatr Neurol 24:193–199

    Article  PubMed  CAS  Google Scholar 

  32. Gungor S, Akinci A, Firat AK et al (2008) Neuroimaging findings in hyperargininemia. J Neuroimaging 18:457–462

    Article  PubMed  Google Scholar 

  33. Roze E, Azuar C, Menuel C et al (2007) Usefulness of magnetic resonance spectroscopy in urea cycle disorders. Pediatr Neurol 37:222–225

    Article  PubMed  Google Scholar 

  34. Albayram S, Murphy KJ, Gailloud P et al (2002) CT findings in the infantile form of citrullinemia. AJNR 23:334–336

    PubMed  Google Scholar 

  35. Wong YC, Au WL, Xu M et al (2007) Magnetic resonance spectroscopy in adult-onset citrullinemia: elevated glutamine levels in comatose patients. Arch Neurol 64:1034–1037

    Article  PubMed  Google Scholar 

  36. Valanne L, Ketonen L, Majander A et al (1998) Neuroradiologic findings in children with mitochondrial disorders. AJNR 19:369–377

    PubMed  CAS  Google Scholar 

  37. Chu BC, Terae S, Takahashi C et al (1999) MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 41:759–764

    Article  PubMed  CAS  Google Scholar 

  38. Kapeller P, Fazekas F, Offenbacher H et al (1996) Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome. J Neurol Sci 135:126–130

    Article  PubMed  CAS  Google Scholar 

  39. Hirano M, Silvestri G, Blake DM et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727

    PubMed  CAS  Google Scholar 

  40. Gordon N (2006) Alpers syndrome: progressive neuronal degeneration of children with liver disease. Dev Med Child Neurol 48:1001–1003

    Article  PubMed  Google Scholar 

  41. Afifi AK, Sato Y, Waziri MH et al (1990) Computed tomography and magnetic resonance imaging of the brain in Hurler’s disease. J Child Neurol 5:235–241

    Article  PubMed  CAS  Google Scholar 

  42. Miebach E (2005) Enzyme replacement therapy in mucopolysaccharidosis type I. Acta Paediatr Suppl 94:58–60

    Article  PubMed  CAS  Google Scholar 

  43. Bembi B, Ciana G, Mengel E et al (2002) Bone complications in children with Gaucher disease. Br J Radiol 75 [Suppl 1]:A37–A44

    PubMed  Google Scholar 

  44. Elstein D, Abrahamov A, Dweck A et al (2002) Gaucher disease: pediatric concerns. Paediatr Drugs 4:417–426

    PubMed  Google Scholar 

  45. Hermann G, Pastores GM, Abdelwahab IF (1997) Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 26:687–696

    Article  PubMed  CAS  Google Scholar 

  46. McCormack PL, Goa KL (2003) Miglustat. Drugs 63:2427–2434

    Article  PubMed  CAS  Google Scholar 

  47. McHugh K, Olsen OE, Vellodi A (2004) Gaucher disease in children: radiology of non-central nervous system manifestations. Clin Radiol 59:117–123

    Article  PubMed  CAS  Google Scholar 

  48. Vom DS, Poll L, Di Rocco M et al (2006) Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 22:1045–1064

    Article  CAS  Google Scholar 

  49. Seto T, Kono K, Morimoto K et al (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50:79–92

    Article  PubMed  CAS  Google Scholar 

  50. Vedolin L, Schwartz IV, Komlos M et al (2007) Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69:917–924

    Article  PubMed  CAS  Google Scholar 

  51. Wilken B, Dechent P, Hanefeld F et al (2008) Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine. Eur J Paediatr Neurol 12:56–60

    PubMed  CAS  Google Scholar 

  52. Yamada H, Ohya M, Higeta T et al (1987) Craniosynostosis and hydrocephalus in I-cell disease (mucolipidosis II). Childs Nerv Sys 3:55–57

    Article  CAS  Google Scholar 

  53. Rodrigues R, Marchiori E, Muller NL (2004) Niemann-Pick disease: high-resolution CT findings in two siblings. J Comput Assist Tomogr 28:52–54

    Article  PubMed  Google Scholar 

  54. Palmeri S, Battisti C, Federico A et al (1994) Hypoplasia of the corpus callosum in Niemann-Pick type C disease. Neuroradiology 36:20–22

    Article  PubMed  CAS  Google Scholar 

  55. Tedeschi G, Bonavita S, Barton NW et al (1998) Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. J Neurol Neurosurg Psychiatry 65:72–79

    Article  PubMed  CAS  Google Scholar 

  56. Lidove O, Klein I, Lelievre JD et al (2006) Imaging features of Fabry disease. AJR 186:1184–1191

    Article  PubMed  Google Scholar 

  57. Choi S, Enzmann DR (1993) Infantile Krabbe disease: complementary CT and MR findings. AJNR 14:1164–1166

    PubMed  CAS  Google Scholar 

  58. Kim TS, Kim IO, Kim WS et al (1997) MR of childhood metachromatic leukodystrophy. AJNR 18:733–738

    PubMed  CAS  Google Scholar 

  59. Kruse B, Hanefeld F, Christen HJ et al (1993) Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 241:68–74

    Article  PubMed  CAS  Google Scholar 

  60. Boxer RA, Fishman M, LaCorte MA et al (1986) Cardiac MR imaging in Pompe disease. J Comput Assist Tomogr 10:857–859

    Article  PubMed  CAS  Google Scholar 

  61. van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P et al (2000) Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol 47:540–543

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author is a medical advisor for some of the companies developing and marketing ultra-orphan drugs, is an invited speaker at some of their conferences, and has received travel grants and honoraria from them.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chris J. Hendriksz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hendriksz, C.J. Inborn errors of metabolism for the diagnostic radiologist. Pediatr Radiol 39, 211–220 (2009). https://doi.org/10.1007/s00247-008-1072-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-008-1072-x

Keywords

Navigation